Inception Return
(10/28/1996)
|
9.60 %
|
|
YTD Return
|
2.99 %
|
|
NAVPS
(9/5/2025)
|
$218.17
|
|
Change
|
$1.04 / 0.48 %
|
|
|
Growth of $10,000
(As of July 31, 2025)
|
|
MER
|
2.23 %
|
|
Assets ($mil)
|
$440.23
|
|
Rank (1Yr)
|
1406/2046
|
|
Std Dev (3Yr)
|
15.88 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. We will not change the Fund’s fundamental investment objectives without the consent of unitholders by a majority of votes cast at a meeting of unitholders.
|
Fund Manager
CIBC Asset Management Inc.
Portfolio Manager
Mark Lin, CIBC Asset Management Inc.
Sub-Advisor
-
|
|
Asset Allocation
(As of July 31, 2025)
|
Sector Allocation
(As of July 31, 2025)
|
Geographic Allocation
(As of July 31, 2025)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| NVIDIA Corp | US Equity | Technology | United States | 10.39% |
| Microsoft Corp | US Equity | Technology | United States | 8.73% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 7.52% |
| Apple Inc | US Equity | Technology | United States | 7.21% |
| Meta Platforms Inc Cl A | US Equity | Technology | United States | 6.46% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 4.46% |
| Roche Holding AG - Partcptn | International Equity | Healthcare | Other European | 4.33% |
| Novartis AG Cl N | International Equity | Healthcare | Other European | 4.20% |
| Broadcom Inc | US Equity | Technology | United States | 4.19% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 3.87% |
Performance Data
(As of July 31, 2025)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
3.94
|
13.57
|
-1.59
|
2.99
|
9.67
|
17.86
|
10.10
|
14.73
|
|
Benchmark
|
2.87
|
12.34
|
3.36
|
7.43
|
16.06
|
18.12
|
13.49
|
10.74
|
|
Quartile Ranking
|
1
|
1
|
4
|
4
|
3
|
1
|
3
|
1
|
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|
Fund
|
30.67
|
30.23
|
-20.88
|
3.16
|
47.03
|
34.81
|
7.27
|
31.06
|
-3.31
|
30.53
|
|
Benchmark
|
26.84
|
19.37
|
-12.64
|
17.62
|
13.15
|
21.41
|
-1.79
|
16.29
|
5.18
|
16.88
|
|
Quartile Ranking
|
1
|
1
|
4
|
4
|
1
|
1
|
1
|
1
|
4
|
1
|